Stock page
EV Biologics Inc (YECO)
EV Biologics Inc enables EV Biologics to accelerate its nanotherapeutic biomanufacturing process and producer-cell line development through Lonza's infrastructure and deep expertise in cell and gene therapy. It has been developing nanotherapeutic-producing cells and optimizing a method for isolating cells from tissue, as well as expanding cell banks using defined cell culture conditions.
Quote snapshot
$0.0915
Daily change: —
ExchangeOTCPK
Updated2026-05-09T03:35:40.333772Z
Price chart
Price history
| Name |
|---|
| Revenue |
| Cost Of Goods Sold |
| Gross Profit |
| Gross Margin % |
| Research Development |
| Selling General Admin Expense |
| Depreciation Depletion Amortization |
| Other Operating Expense |
| Total Operating Expense |
| Operating Income |
| Operating Margin |
| Interest Income |
| Interest Expense |
| Other Income Expense |
| Other Income Minority Interest |
| Other Net Income Loss |
| Ebit |
| Ebitda |
| Ebitda Margin |
| Pretax Income |
| Tax Provision |
| Tax Rate |
| Net Income Continuing Operations |
| Net Income Discontinued Operations |
| Net Income |
| Net Income Including Noncontrolling Interests |
| Is Preferred Dividends |
| Shares Outstanding |
| Eps Basic |
| Eps Diluted |
| Net Margin |
SEC filings
Latest 10-K filing table
| Date | Form | Accession | Link |
|---|